倪福达与倍他乐克联用治疗原发性高血压临床观察

COMBINATION OF NIFUDA WITH BETALOC IN THE TREATMENT OF ESSENTIAL HYPERTENSION

目的探讨伲福达和倍他乐克联合小剂量应用治疗原发性高血压病人的效果。方法将高血压病人64例随机分为观察组和对照组（各32例）。观察组给予伲福达每次10 mg,每天2次,倍他乐克每次12.5～25.0 mg,每天2次。对照组病人给予伲福达治疗,每次20 mg,每天2次。两组均连用6周,比较两组的降压效果。结果观察组治疗高血压的疗效明显优于对照组（uc=12.08,P〈0.01）。观察组临床症状改善优于对照组（uc=31.05,P〈0.01）。结论倪福达与倍他乐克联用治疗原发性高血压疗效较好。

Objective To assess the efficacy of low-dose Nifuda and Betaloc combination for essential hypertension. Methods The patients were randomized into observation group and control group.Those in observation group were given Nifuda,10 mg,and Betaloc,12.5-25.0 mg,twice daily separately;those in control group,Nifuda only,20 mg,twice daily.The course was 6 weeks for both groups. Results The better outcomes were achieved in observation group（uc=12.08,P〈0.01） including the symptoms improved（uc=31.05,P〈0.01）. Conclusion A better therapeutic outcome can be reached for essential hypertension by combining Nifuda with Betaloc.